Effects and safety of GnRH-a as a luteal support in women undertaking assisted reproductive technology procedures: follow-up results for pregnancy, delivery, and neonates

Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts

Mercedes de Onís, Cutberto Garza, Adelheid W. Onyango et al. · Journal of Nutrition · 2007 · 480 citations

Public Health, Child Health, Pediatrics +16

Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles

Jan Tesařík, A. Hazout, Raquel Mendoza‐Tesarik et al. · Human Reproduction · 2006 · 158 citations

Veterinary Medicine, Endocrinology, Gynecology +17

Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin  3 and leukaemia-inhibitory factor and improves uterine receptivity in mice

H Ruan, Ximei Zhu, Qiaojie Luo et al. · Human Reproduction · 2006 · 109 citations · Full text

Medicine, Endocrinology, Gynecology +15

The luteal phase after 3 decades of IVF: what do we know?

H.M. Fatemi · Reproductive BioMedicine Online · 2009 · 87 citations

Veterinary Medicine, Endocrinology, Gynecology +12

Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients

Juan Balasch, Francisca Martínez, Inmaculada Jové et al. · Human Reproduction · 1993 · 45 citations

Medicine, Endocrinology, Gynecology +14